Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.

about

Lipid-lowering efficacy of rosuvastatin HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).

P2860

Q24187891-36C56FAB-0E9C-40C0-816C-82C9A57A21B9 Q38809604-790C9A7C-A261-443E-8714-D35CFE3A49FA

P2860

Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.

Item

http://www.wikidata.org/entity/Q38236677

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Addition of omega-3 carboxylic ...... rsistent hypertriglyceridemia.

@en

type

Item

label

Addition of omega-3 carboxylic ...... rsistent hypertriglyceridemia.

@en

prefLabel

Addition of omega-3 carboxylic ...... rsistent hypertriglyceridemia.

@en

P1476

Addition of omega-3 carboxylic ...... rsistent hypertriglyceridemia.

@en

P2093

Alyssa K Phillips

http://www.w3.org/2001/XMLSchema#string

Douglas Kling

http://www.w3.org/2001/XMLSchema#string

Kevin C Maki

http://www.w3.org/2001/XMLSchema#string

Michael H Davidson

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

The evolving role of statins in the management of atherosclerosis.

Effects of combination lipid therapy in type 2 diabetes mellitus.

P304

1045-1054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.942640

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25089906

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy

Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.

about

P2860

P2860

Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921